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Summary Peripheral tissue damage or nerve injury often leads to pathological pain processes, such as 
spontaneous pain, hyperalgesia and allodynia, that persist for years or decades after all possible tissue healing has 
occurred. Although peripheral neural mechanisms, such as nociceptor sensitization and neuroma formation, 
contribute to these pathological pain processes, recent evidence indicates that changes in central neural function 
may also playa significant role. In this review, we examine the clinical and experimental evidence which points to a 
contribution of central neural plasticity to the development of pathological pain. We also assess the physiological, 
biochemical, cellular and molecular mechanisms that underlie plasticity induced in the central nervous system 
(eNS) in response to noxious peripheral stimulation. Finally, we examine theories which have been proposed to 
explain how injury or noxious stimulation lead to alterations in eNS function which influence subsequent pain 
experience. 
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Introduction 
The somatosensory system normally serves the valu-
able function of alerting the individual to actual or 
potential tissue damage. However, following peripheral 
tissue or nerve injury, a pathological state sometimes 
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develops in which there is a reduction in pain thresh-
old (allodynia), an increased response to noxious stim-
uli (hyperalgesia), an increase in the duration of re-
sponse to brief stimulation (persistent pain) and a 
spread of pain and hyperalgesia to uninjured tissue 
(referred pain and secondary hyperalgesia). The most 
distressing feature of these pathological processes is 
that they persist long after healing of the damaged 
peripheral tissue. Peripheral neural mechanisms, such 
as nociceptor sensitization and neurogenic responses 
are likely to contribute to pathological pain at early 
stages following injury when tissue damage and inflam-
mation are prevalent. However, the persistence of 
pathological pain after the healing of damaged tissue 
suggests that changes in eNS function may also playa 
significant role. In the present paper, we examine the 
clinical and experimental evidence which indicates that 
central neural plasticity contributes to the development 
of pathological pain. We also assess the physiological, 
biochemical, cellular and molecular changes that de-
velop within the eNS in response to noxious peripheral 
stimulation. Finally, we provide a brief historical re-
view of the development of the idea that pain pro-
cesses·are influenced by noxious stimulus-induced plas-
HClty, and examine recent theories that have been 
proposed to explain how peripheral injury or noxious 
stimulation leads to eNS alterations which contribute 
to pathological pain processes. 
Clinical and experimental evidence that CNS plasticity 
contributes to pathological pain 
Damage of peripheral tissue and injury to nerves 
typically produce persistent pain and hyperalgesia. 
However, there are significant differences in the under-
lying peripheral mechanisms of nociceptive and neuro-
pathic pain. Damage of cutaneous or deep (muscle, 
joint and viscera) tissue is typically associated with 
peripheral inflammation, while injury of nerves often 
leads to pathological peripheral nerve processes, in-
cluding neural degeneration, neuroma formation and 
the generation of spontaneous neural inputs. It is gen-
erally accepted that the nociceptive pain produced by 
tissue injury is significantly influenced by peripheral 
inflammatory changes, while neuropathic pain is influ-
enced by pathological alterations in peripheral nerve 
function. Evidence suggests that although nociceptive 
and neuropathic pain depend on separate peripheral 
mechanisms, they are both significantly influenced by 
changes in eNS function. 
A role of central plasticity in nociceptive pain 
Secondary hyperalgesia 
Hardy et al. (1950) proposed that there are two 
types of hyperalgesia: primary and secondary. Primary 
hyperalgesia involves increased sensitivity to noxious 
stimulation at the site of an injury, while secondary 
hyperalgesia involves increased sensitivity extending 
beyond the site of the injury, sometimes to remote sites 
distant from the site of injury. These investigators 
proposed that primary hyperalgesia was mediated by 
peripheral mechanisms (i.e., neurogenic inflammation), 
while secondary hyperalgesia was related to central 
hyperactivity or sensitization. This conclusion was based 
on their observation that hyperalgesia spread beyond 
the region of the flare response, which was known to 
be produced by neurogenic inflammation, and by the 
finding that the development of hyperalgesia after cu-
taneous injury was prevented by prior local anesthetic 
blocks of peripheral nerves proximal to the site of 
injury. 
Recent evidence supports the view that hyperalgesia 
depends, in part, on central sensitization. Hyperalgesia 
to punctate mechanical stimuli, which develops after 
intradermal injection of capsaicin, is maintained even 
after anesthetizing the region where capsaicin was in-
jected (LaMotte et al. 1991). However, if the skin 
region is anesthetized prior to capsaicin injection, cuta-
neous hyperalgesia does not develop. Furthermore, 
hyperalgesic responses to capsaicin can be prevented if 
the area of skin where the injection is made is ren-
dered anesthetic by a proximal anesthetic block of the 
peripheral nerve which innervates it. Thus, for hyperal-
gesia to develop it is critical that initial inputs from the 
injury reach the eNS. However, once hyperalgesia is 
established, it does not need to be maintained by 
inputs from the injured peripheral tissue. In support of 
this, Torebjork et al. (1992) have shown that pain 
thresholds to intraneural electrical stimulation of affer-
ent fibers are dramatically reduced following intrader-
mal capsaicin injection, even when the sensory pro-
jected field of the afferent nerve is anesthetized after 
the capsaicin injection. 
Referred pain and hyperaLgesia 
Further evidence for a central mechanism of hyper-
algesia is suggested by clinical and experimental cases 
of referred pain and hyperalgesia. Hardy et al. (1950) 
demonstrated that hyperalgesia is produced in the chest 
and abdomen following injections of hypertonic saline 
into intraspinous ligaments (also see Kellgren 1938). 
They also reported a case of spontaneous hyperalgesia 
which spread extensively over the skin of the back 
following a minor back injury, and another case of 
hyperalgesia in the face and scalp associated with an 
ear infection. In addition, Lewis (1942) showed that 
referred pain and hyperalgesia in the shoulder can be 
elicited by stimulation of the diaphragm. Indeed, re-
ferred pain and hyperalgesia are often reported in the 
muscle and skin within the same spinal cord der-
matome as injured organs, and are commonly used for 
the diagnosis of conditions such as appendicitis and 
angina pectoris. 
Referred pain appears to depend on neural mecha-
nisms since local anesthesia of the injured region blocks 
its expression (Robertson et al. 1947). Furthermore, 
the role of central neural mechanisms is supported by 
the observation that phrenic nerve stimulation causes 
referred shoulder pain even after the sectioning of an 
cutaneous nerves from the painful region of the shoul-
der (Doran and Ratcliffe 1954), and by the finding that 
the injection of hypertonic saline into intraspinous 
ligaments resulted in pain referred to a phantom arm 
(Harman 1948). It is possible that referred pain de-
pends on the misinterpretation of inputs from an in-
jured region whose axons also branch to the uninjured 
referred area (Sinclair et al. 1948), or alternatively that 
axons from the injured and referred regions converge 
on the same cells in the sensory pathway (Ruch 1965). 
If referred pain could be explained exclusively by con-
vergence, then such pains would not provide clear 
evidence of central sensitization. However, evidence 
that referred pain is also in part dependent on eNS 
changes is provided by findings that referred pain and 
hyperalgesia spread to areas which do not share the 
same dermatome (Lewis 1942; Livingston 1943). For 
example, it has been shown that pain of cardiac origin 
is referred to sites as distant as the patient's ear (Brylin 
and Hindfelt 1984). The fact that pain and hyperalgesia 
can spread to areas far removed from the injured 
region implies that central changes, as opposed to 
convergence, are involved in the spread of hyperalge-
sia. Furthermore, referred pain has often been found 
to spread specifically to sites of a previous injury. 
Henry and Montuschi (1978) describe a case where the 
pain of an angina attack was referred to the site of an 
old vertebral fracture. Furthermore, Hutchins and 
Reynolds (1947) discovered that alterations in baro-
metric pressure during high-altitude flights caused 
many of their patients to complain of pain localized to 
teeth which had been the site of previous painful 
stimulation (e.g., fillings, caries and extractions), in 
many cases years earlier. Reynolds and Hutchins (1948) 
were able to replicate this finding under controlled 
conditions. One week after damaged teeth were filled 
or extracted, pinprick of the nasal mucosa produced 
pain referred to the previously treated teeth. This 
phenomenon occurred among patients who had been 
treated under general anesthesia, but not under the 
influence of a local anesthetic block. Furthermore, in 
patients who had received bilateral dental treatment 
without a local anesthetic, subsequent blocks applied 
to one side permanently abolished the referred pain 
ipsilateral but not contralateral to the anesthetized 
side. 
Behavioral and physiological studies in animals also 
demonstrate hyperalgesia or sensitization in response 
to stimulation of body regions which are at a distance 
from a cutaneous or deep tissue injury. Woolf (1984) 
found that localized thermal and chemical injuries 
cause reductions in flexion reflex thresholds to noxious 
mechanical and thermal stimulation in the limb con-
tralateral as well as ipsilateral to the injury. Following 
inflammatory lesions of the rat knee joint, spinal dorsal 
horn (Neugebauer and Schaible 1990) and thalamic 
(Guildbaud et al. 1986) neurons exhibit an enhanced 
responsiveness not only to mechanical stimulation of 
the inflamed joint, but also to stimulation of the mus-
cles in the thigh and lower regions of both the ipsilat-
eral and contralateral legs. These finding are consis-
tent with clinical observations that hyperalgesia devel-
ops in body regions which are distant from the area of 
a deep tissue injury (Hardy et aI. 1950), and that 
flexion reflex thresholds are reduced in patients follow-
ing gynecological surgery (Dahl et aI. 1992a). 
Cutaneous (Woolf 1983) and deep (Woolf and 
McMahon 1985) tissue injury, as well as noxious elec-
trical stimulation of cutaneous and muscle afferent 
nerves (Wall and Woolf 1984) also produce an increase 
in the excitability of the ipsilateral and contralateral 
flexor efferent nerves in response to noxious mechani-
cal stimulation of the hind paw. Since the increased 
excitability in the contralateral flexor efferent nerve is 
maintained even after inputs from the injured paw are 
blocked by local anesthesia, the results suggest that 
central, not peripheral, changes underlie this effect. In 
this way, cutaneous hyperalgesia after injury may de-
pend on central hypersensitivity which is produced by 
inputs from a peripheral injury, but does not need to 
be maintained by them. Behavioral studies indicate 
that the spread of hyperalgesia to the hind paw con-
tralateral to the paw that received a thermal injury is 
unaffected by either deafferentation or anesthetic 
blocks of the injured hind paw following the injury, but 
is prevented if deafferentation or anesthetic block pre-
cedes the injury (Coderre and Melzack 1985, 1987). 
These data provide further evidence that peripheral 
injury can produce central changes which are main-
tained even after the inputs from the injury are re-
moved. 
Central sensitization 
Prolonged sensory disturbances associated with tis-
sue injury (secondary hyperalgesia and referred pain, 
as well as allodynia and persistent spontaneous pain) 
are believed to result from either a reduction in the 
threshold of nociceptors or an increase in the excitabil-
ity of CNS neurons involved in pain transmission. Since 
there is a large body of evidence documenting the 
sensitization of peripheral receptors following noxious 
stimulation (Beitel and Dubner 1976; Perl 1976; Camp-
bell and Meyer 1983; Koltzenburg et al. 1992), a pe-
ripheral mechanism is usually held to be responsible 
for the hyperalgesia that develops after injury. How-
ever, recent experimental studies suggest that sensitiza-
tion within the CNS also contributes significantly to 
this phenomenon. These studies indicate that following 
injury, noxious stimulation, or C-fiber afferent electri-
cal stimulation, there is a sensitization of neurons in 
the dorsal horn of the spinal cord and other areas in 
the somatosensory pathway. This sensitization is re-
flected by increased spontaneous activity, reduced 
thresholds or increased responsivity to afferent inputs, 
prolonged afterdischarges to repeated stimulation, and 
the expansion of the peripheral recepti'le field of dor-
sal horn neurons. 
Evidence of central sensitization was supported ini-
tially by reports that cutaneous hyperalgesia spreads 
well beyond the area of nociceptor sensitization. Thal-
hammer and LaMotte (1982) found that a heat injury 
in one half of a cutaneous nociceptor's receptive field 
did not produce heat sensitization in the other half, 
despite the fact that hyperalgesia spread into this area. 
Typically, nociceptor sensitization associated with in-
jury is restricted to about 5-10 mm of the site of injury 
(Fitzgerald 1979) while, in contrast, cutaneous hyperal-
gesia spreads as far as 10-20 cm beyond the site of 
injury (Hardy et al. 1950). Furthermore, noxious me-
chanical and chemical stimuli produce extensive. 
spreading hyperalgesia (LaMotte et al. 1992) without 
producing the same degree of spreading sensitization 
of primary afferent nociceptors in monkeys (Campbell 
et al. 1988; Baumann et al. 1991) or humans (LaMotte 
ct al. 1992). 
Coincident with spreading hyperalgesia is the sensi-
tization of spinal cord dorsal horn neurons. Dorsal 
horn neurons fire with increasing frequency in re-
sponse to repeated applications of a noxious heat stim-
ulus (Perl 1976; Kenshalo et al. 1979). This sensitiza-
tion of dorsal horn neurons occurs after various types 
of tissue injury including thermal injury (Price et al. 
1978; Kenshalo et a1. 1982), chemical injury (Simone et 
al. 1991; Dougherty and Willis 1992), acute joint in-
flammation (Schaible et al. 1987; Dougherty et al. 
1992c), polyarthritis (Menetrey and Besson 1982; 
Calvi no et al. 1987) or stimulation of C-fiber afferents 
(Chung et al. 1979). Sensitization in response to tissue 
injury /inflammation or electrical nerve stimulation also 
occurs in spinal motoneurons (Woolf 1983), thalamus 
(Guilbaud et al. 1986), and somatosensory cortex 
(Lamour et a!. 1983). Furthermore, repeated C-fiber 
afferent stimulation sequentially increases dorsal horn 
activity resulting in a prolonged discharge of the cell, 
lasting from seconds to minutes post-stimulation 
(Mendell 1966; Schouenbourg and Dickenson 1985). 
This phenomenon, which has been labelled as 'windup' 
(Mendell 1966), could potentially occur following in-
tense noxious stimulation or injury. 
In addition to the sensitization and prolonged exci-
tation of dorsal horn cells, noxious stimulation associ-
ated with tissue injury also produces an expansion of 
the receptive fields of dorsal horn neurons. Neurons in 
the dorsal horn of the spinal cord with receptive fields 
adjacent to a cutaneous heat injury expand their recep-
tive fields to incorporate the site of injury (McMahon 
and Wall 1984). Similar recept~ve field expansions have 
been observed in spinal cord following mechanical 
(Cervero et al. 1988), chemical (Hoheisel and Mense 
1989; Woolf and King 1990), inflammatory (Hylden et 
a!. 1989) and nerve (Devor and Wall 1978) injuries, as 
well as following the induction of polyarthritis (Menetry 
and Besson 1982; Calvino et al. 1987) and in response 
to electrical nerve stimulation (Cook et al. 1987). Re-
ceptive field expansions have also been observed in 
trigeminal brainstem neurons following chemical stimu-
lation of deep craniofacial afferents (Hu et a!. 1992). 
Inflammatory lesions also produce an expansion of 
receptive fields of cells in the ventrobasal thalamus 
(Guilbaud et al. 1986). 
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A role of central plasticity in neuropathic pain 
Pain in phantom limbs and deafferented structures 
A striking property of phantom limb pain is the 
persistence of a pain that existed in a limb prior to its 
amputation (Melzack 1971). This type of phantom limb 
pain, characterized by the persistence or recurrence of 
a previous pain, has the same qualities and is experi-
enced in the same area of the limb as the pre-amputa-
tion pain. Case studies of amputees (see Katz and 
Melzack 1990) have demonstrated pain 'memories' of 
painful diabetic and decubitus ulcers, gangrene, corns, 
blisters, ingrown toe nails, cuts and deep tissue injury. 
In addition, the phantom limb may assume the same 
painful posture as that of the real limb prior to ampu-
tation, especially if the arm or leg had been immobi-
lized for a prolonged period (Katz and Melzack 1990). 
The literature indicates that the proportion of am-
putees who report that their phantom pains are similar 
to those felt in the limb before amputation may be as 
high as 79% (Katz and Melzack 1990). Reports of pain 
memories in phantom limbs appear to be less common 
when there has been a discontinuity, or a pain-free 
interval, between the experience of pain and the ampu-
tation. This is consistent with the observation that 
relief of pre-amputation pain by continuous epidural 
block for 3 days prior to amputation decreases the 
incidence of phantom limb pain 6 months later (Bach 
et al. 1988). Furthermore, if pain is experienced at or 
near the time of amputation, there is a higher probabil-
ity that it will persist in the phantom limb (Jensen et al. 
1985; Katz and Melzack 1990). 
Pain also persists in patients with deafferentation 
that does not involve amputation. Patients with brachial 
plexus avulsions (Reisner 1981; Jensen and Rasmussen 
1989) and spinal cord injuries often experience pain in 
the anesthetic, de·afferented region (Conomy 1973; 
Berger and Gerstenbrand 198]). For example, Nathan 
(1962) described a patient who continued to feel the 
pain of an ingrown toe nail after a complete spinal 
cord break. In addition, patients undergoing spinal 
anesthesia (Van Bogaert 1934; Wallgren 1954) and 
those with injuries of the brachial plexus (Reisner 
1981; Jensen and Rasmussen 1989) or spinal cord 
(Conomy 1973; Berger and Gerstenbrand 1981) some-
times report that a limb is in the same uncomfortable, 
often painful posture it was in prior to the injury or 
block. These postural phantom sensations do not usu-
ally persist beyond several days, and in most cases arc 
at least temporarily reversed by competing visual in-
puts which reveal a dissociation between the real and 
perceived limb. 
There is also a literature on the persistence of 
painful and non-painful sensations associated with re-
moval or deafferentation of body structures other than 
the limbs, including breasts (Kroner et al. 1989), teeth 
(Hutchins and Reynolds 1947; Reynolds and Hutchins 
1948), and internal and special sense organs. Ulcer 
pain has been reported to persist after vagotomy (Szasz 
1949) or subtotal gastrectomy with removal of the ulcer 
(Gloyne 1954). Similarly, patients have reported labor 
pain and menstrual cramps following total hysterec-
tomy (Dorpat 1971), rectal and hemorrhoid pain fol-
lowing removal of the rectum (Ovesen et al. 1991), the 
burning pain of cystitis after complete removal of the 
bladder (Brena and Sammons 1979), and the pain of a 
severely ulcerated cornea after enucleation of an eye 
(Minski 1943). 
When a missing or completely anesthetic limb con-
tinues to be the source of pain which resembles an old 
injury, it is reasonable to assume that the pain is 
centrally represented, but it is not clear whether deaf-
ferentation per se is necessary for pain memories to 
develop. The interruption of afferent input associated 
with deafferentation may facilitate the central neural 
changes that contribute to the formation of pain mem-
ories by removing normal inhibitory control mecha-
nisms (see below). In addition, since amputation also 
results in the loss of visual and tactile information 
related to the limb, the central influences that normally 
inhibit the established pain 'traces' may be reduced 
further by the absence of information from external 
sources that could confirm or disconfirm the percept 
arising from the peripheral injury. 
There is evidence that in some instances the reacti-
vation of pain memories requires a peripheral trigger. 
Leriche (1947a,b) described a patient who did not 
experience phantom limb pain until 6 years after am-
putation, when an injection into the stump instantly, 
and permanently, revived the pain of a former painful 
ulceration of the Achilles tendon. Nathan 0962, 1985) 
reported a similar phenomenon when applying noxious 
stimulation to the stump of an amputee who later 
re-experienced the pain of an ice-skating injury he had 
sustained 5 years earlier when the leg was intact. 
Noordenbos and Wall (1981) also described 7 patients 
with partial peripheral nerve injury, and subsequent 
pain, who underwent complete nerve resection and 
graft or ligation. Following regeneration and a pain-free 
period, all re-developed pain of the same quality and in 
the same location as the pain they had experienced 
prior to nerve resection, although in some patients the 
recurrence of pain was restricted to a smaller area 
within the originally painful region. These studies and 
case reports indicate that past pains may be reactivated 
months or even years after the original injury, in some 
cases by a peripheral trigger which provides the input 
required to activate the central neural structures sub-
serving the memory trace. 
Deafferentation pain in animals 
Deafferentation by peripheral neurectomy or dorsal 
rhizotomy in rodents is followed by self-mutilation (au-
totomy) in which the animals bite and scratch the 
insensate paw to the point of amputation (Wall et al. 
1979). There is evidence that autotomy behavior is 
produced by ongoing pain or dysesthesia, associated 
with increased neuronal activity, which is referred to 
the anesthetic region (Coderre et al. 1986a; Blu-
menkopf and Lipman 1991; however, also see Sweet 
1981; Rodin and Kruger 1984). Autotomy behavior is 
dramatically affected by alterations in the level of 
noxious input present at the time of, or prior to, nerve 
section. Thus, noxious chemical (Dennis and Melzack 
1979; Coderre et al. 1986b), thermal (Coderre and 
Melzack 1985, 1987; Katz et al. 1991) and electrical 
(Katz et aI. 1991; Selzter et aI. 1991a) stimulation prior 
to nerve sections significantly increases the severity of 
autotomy following neurectomy or rhizotomy. These 
findings suggest that the prior injury produces central 
changes which influence nociceptive behavior, after 
nerve sections, at a time when inputs from the injured 
region are no longer capable of transmitting their 
message centrally. 
The above findings are similar to clinical repor.ts 
that phantom limb pain is more likely to occur in 
amputees who had pain in their limb prior to amputa-
tion (Melzack 1971), and strongly suggest that central 
neuroplasticity is crucial to the development of phan-
tom limb pain. The clinical relevance of these findings 
is indicated by the observation that in human amputees 
.the incidence of phantom limb pain at 7 days and 6 
months after amputation is significantly greater in pa-
tients whose pain is not treated by epidural block with 
bupivacaine and morphine prior to amputation surgery 
(Bach et al. 1988). In contrast to the effect of increas-
ing noxious inputs at the time of nerve injury, reducing 
or eliminating the afferent barrage induced by nerve 
section produces a dramatic reduction in autotomy. 
When the afferent barrage induced by nerve cuts in 
rats is blocked by treating the sciatic and saphenous 
nerves with local anesthetics prior to sectioning them, 
there is a significant reduction in the incidence and 
severity of autotomy (Gonzalez-Darder et al. 1986; 
Seltzer et al. 1991a). 
An animal model has recently been developed (Katz 
et al. 1991) which parallels the observation that human 
amputees report similar pains in a limb before and 
after amputation. In this animal model, rats selectively 
initiated autotomy in either the lateral or medial half 
of a hind paw if that particular half had been given a 
thermal injury prior to sciatic and saphenous nerve 
sections. The selective attack on the previously injured 
region, despite the fact that the entire foot was deaf-
ferented, suggests that the rats were responding to 
pain referred to the injured area, which was produced 
by the prior injury and the central trace it created. 
Rats injured after neurectomy did not show a similar 
preference indicating that the rats were not responding 
simply to peripheral cues associated with the injury. 
While the autotomy model has provided evidence 
for a contribution of central plasticity to pain associ-
ated with peripheral nerve injury, its usefulness as a 
model of neuropathic pain has been questioned since it 
suffers from the weakness of lacking many of the signs 
of neuropathic pain found in humans. Recently, an 
animal model of peripheral neuropathy has been devel-
oped which produces behavioral signs of hyperalgesia, 
allodynia and spontaneous pain or dysesthesia, which 
are proposed to resemble the symptoms of nerve in-
jury-related pain in humans. This model involves the 
placing of loosely constrictive ligatures around the sci-
atic nerve in rats and observing the behavioral symp-
toms associated with the nerve pathology that develops 
over the next several days (Bennett and Xie 1988). 
Recent evidence suggests that the nerve constriction 
injury produces profound changes in spinal cord physi-
ology, including transynaptic degeneration (Sugimoto 
et al. 1990), increases in c-[os expression (Kajander et 
al. 1990) and the growth-associated protein GAP 43 
(Cameron et al. 1991), as well as decreases in tachykinin 
immunoreactive staining (Bennett et al. 1989; Cameron 
et al. 1991) in the dorsal horn. The injury also produces 
increased spontaneous activity and increased excitabil-
ity (lowered thresholds to mechanical stimulation, and 
afterdischarges to suprathreshold stimuli) of spinotha-
lamic tract cells (Palecek et a1. 1992), as well as the 
generation of spontaneous discharges in the dorsal root 
ganglion (Kajander et al. 1992). Furthermore, the con-
striction injury produces a dramatic increase in spinal 
cord metabolic (2-DG) activity in both the ipsilateral 
and contralateral spinal cord (Mao et al. 1992a). Since 
metabolic activity is increased in the absence of addi-
tional peripheral stimulation it has been argued that 
the behavioral symptoms are driven by sustained alter-
ations in spinal cord function. This notion is supported 
by the finding that there is a reduction in the hyperal-
gesia that develops following constriction injury of the 
sciatic nerve if the nerve is locally anesthetized at the 
time of injury (Dougherty et aJ. 1992a). Furthermore, 
while hyperalgesia and spontaneous pain produced by 
nerve constriction injury are reduced by post-injury 
local anesthesia of the sciatic nerve (Mao et al. 1992b). 
suggesting a peripheral contribution to the pain pathol-
ogy, hyperalgesia and spontaneous pain are also re-
duced by systemic or intrathecal treatment with N-
methyl-D-aspartate (NMDA) antagonists (Davar et a1. 
1991; Mao et al. 1992b), suggesting a central contribu-
tion as well. 
Denercation hypersensitidty and neuronal hyperactivity 
Sensory disturbances associated with nerve injury 
have been closely linked to alterations in CNS func-
tion. Markus et al. (1984) have demonstrated that the 
development of hypersensitivity in a rat's hind paw 
following sciatic nerve section occurs concurrently with 
the expansion of the saphenous nerve's somatotopic 
projection in the spinal cord. Nerve injury may also 
lead to the development of increased neuronal activity 
at various levels of the somatosensory system. In addi-
tion to spontaneous activity generated from the neu-
roma (Wall and Gutnik 1974), peripheral neurectomy 
also leads to increased spontaneous activity in the 
dorsal root ganglion (Wall and Devor 1983; Burchiel 
1984), dorsal spinal roots (Howe et a1. 1977; Wiesen-
feld and Lindblom 1980) and spinal cord (David and 
Aguayo 1980; Asada et al. 1990). Furthermore, after 
dorsal rhizotomy, there are increases in spontaneous 
neural activity in the dorsal horn (Loeser and Ward 
1967; Basbaum and Wall 1976), the spinal trigeminal 
nucleus (Anderson et al. 1971; Macon 1979) and the 
thalamus (Lombard et al. 1979; Albe-Fessard and 
Lombard 1983). 
Clinical neurosurgery studies reveal a similar rela-
tionship between denervation and CNS hyperactivity. 
Neurons in the somatosensory thalamus of patients 
with neuropathic pain display high spontaneous firing 
rates, abnormal bursting activity, and evoked responses 
to stimulation of body areas that normally do not 
activate these neurons (Gorecki et a1. 1989; Hirayama 
et al. 1989; Lenz et al. 1989; Rinaldi et al. 1991). The 
site of abnormality in thalamic function appears to be 
somatotopically related to the painful region. In pa-
tients with complete spinal cord transection and dyses-
thesias referred below the level of the break, neuronal 
hyperactivity was observed in thalamic regions that had 
lost their normal sensory input, but not in regions with 
apparently normal afferent input (Lenz et al. 1987. 
1988). Furthermore, in patients with neuropathic pain. 
electrical stimulation of subthalamic, thalamic and cap-
sular regions may evoke pain and in some instances 
even reproduce the patient's pain (Nathan 1985; 
Gorecki et al. 1989; Hirayama et a1. 1989; Tasker 
1989). Direct electrical stimulation of spontaneously 
hyperactive cells evokes pain in some but not all pain 
patients, raising the possibility that in certain patients 
the observed changes in neuronal activity may con-
tribute to the perception of pain (Lenz et al. 1988). 
Studies of patients undergoing electrical brain stimula-
tion during brain surgery reveal that pain is rarely 
elicited by test stimuli unless the patient suffers from a 
chronic pain problem. However, brain stimulation can 
elicit pain responses in patients with chronic pain that 
does not involve extensive nerve injury or deafferenta-
tion. Nathan (1985) describes a patient who underwent 
thalamic stimulation for a movement disorder. The 
patient had been suffering from a toothache for 10 
days prior to the operation. Electrical stimulation of 
the thalamus reproduced the toothache. 
It is possible that receptive field expansions and 
spontaneous activity generated in the CNS following 
peripheral nerve injury are, in part, mediated by alter-
ations in normal inhibitory processes in the dorsal 
horn. Within 4 days of a peripheral nerve section there 
is a reduction in the dorsal root potential, and there-
fore, in the presynaptic inhibition it is assumed to 
represent (Wall and Devor 1981). Nerve section also 
induces a reduction in the inhibitory effect of A-fiber 
stimulation on activity in dorsal horn neurons (Woolf 
and Wall 1982). Furthermore, nerve injury affects de-
scending inhibitory controls from brain stem nuclei. In 
the intact nervous system, stimulation of the locus 
coeruleus (Segal and Sandberg 1977) or the nucleus 
raphe magnus (Oliveras et al. 1979) produces an inhibi-
tion of dorsal horn neurons. Following dorsal rhizoto-
my, however, stimulation of these areas produces exci-
tation, rather than inhibition, in half the cells studied 
(Hodge et al. 1983). 
Effects of anesthetic or analgesic pretreatment on post-
injury pain 
Persistent pain in animals 
As noted above, deafferentation pain in rats is sig-
nificantly reduced if the injured nerves are locally 
anesthetized prior to nerve injury. Thus, autotomy af-
ter nerve sections (Gonzalez-Darder et al. 1986; Seltzer 
et aI. 1991a), or hyperalgesia following nerve ligation 
(Dougherty et al. 1992a), is significantly reduced if the 
sciatic and saphenous nerves are locally anesthetized 
prior to the nerve injury. Recent evidence indicates 
that persistent pain induced by tissue injury is also 
reduced by pretreatment with local anesthetics or opi-
oids prior to the injury, suggesting a contribution of 
central plasticity to nociceptive pain. A subcutaneous 
injection of dilute formalin produces a biphasic noci-
ceptive response with an early phase of intense pain 
that occurs in the first few minutes and a later tonic 
phase of moderate pain occurring about 20-60 min 
after formalin injection (Dubuisson and Dennis 1977). 
The nociceptive response to subcutaneous formalin is 
matched by a corresponding biphasic increase in the 
activity of dorsal horn neurons after formalin injection 
(Dickenson and Sullivan 1987b). Dickenson and Sulli-
van (]987b) have demonstrated that intrathecal admin-
istration of a mu-opiate agonist significantly inhibits 
the prolonged increase in dorsal horn activity produced 
by subcutaneous formalin injection. However, this inhi-
bition occurs only if the drug is given before the 
formalin injection, and not if it is given 2 min after the 
injection. These results imply that the dorsal horn 
activity associated with the late phase of the formalin 
test depends upon spinal activation during the early 
phase immediately after formalin injection. 
Behavioral studies support the electrophysiological 
finding that the late-phase response to formalin is, in 
part, dependent on spinal changes generated during 
the early phase. Tonic nociceptive responses in the late 
phase of the formalin test (30-60 min after formalin) 
are not eliminated by complete anesthetic blockade of 
the formalin injected area at the time of testing during 
the late phase, but are virtually abolished if the area 
was also blocked by local anesthetics at the time of 
formalin injection (Coderre et al. 1990). Furthermore, 
late-phase nociceptive responses are significantly re-
duced by spinal anesthesia induced immediately prior 
to formalin injection, but not by spinal anesthesia 
administered 5 min after formalin injection, that is, 
after the early phase had already occurred (Coderre et 
al. 1990). These results suggest that central neural 
changes, which occur during the early phase of the 
formalin test, are essential for the development of the 
later tonic phase of the formalin test. 
Evidence suggests that peripheral tissue injury also 
induces plasticity in supraspinal structures, which af-
fects persistent pain behavior. This evidence comes 
from assessing the effects of pre-injury treatment with 
local anesthetics (in this case injected into discrete 
brain regions) on post-injury pain responses. Nocicep-
tive responses to subcutaneous formalin injection into 
the rat hind paw are suppressed after focal injection of 
lidocaine into specific limbic system sites such as the 
cingulum bundle and the fornix pathway. The lidocaine 
injection produces analgesia during the late phase of 
the formalin test (30-70 min after formalin injection) 
when injected into these areas 10 min before, but not 
10 min after, the formalin injection (Vaccarino and 
Melzack 1992). These results suggest that activity in 
the cingulum bundle and fornix during the early-phase 
response to formalin is critical to the development of 
the late-phase response to formalin. The cingulum 
bundle and fornix are part of a neural loop that pro-
jects from the anterior thalamic nuclei to the cingulate 
cortex, hippocampus and mammillary bodies, and re-
turns to the anterior thalamic nuclei (Papez 1937; 
Vinogradova 1975). It is proposed that activation of 
this 'closed' circuit during the early phase of the forma-
lin response induces a sensitized state within the limbic 
system, enhancing responses to subsequent stimulation. 
Recent physiological evidence supports this concept. 
Brainstem stimulation has been found to enhance the 
responsiveness of the anterior thalamic nuclei to stimu-
lation of the mammillary bodies and cingulate cortex 
(Pare et al. 1990). Furthermore, noxious peripheral 
stimulation produces bursting activity in CAl neurons 
of the hippocampus (Sinclair and Lo 1986). The selec-
tive blocking of neural activity in the cingulum bundle 
or fornix during the early phase of formalin may re-
duce nociceptive responses by preventing the develop-
ment of long-term changes in these structures. 
Post-operative pain 
The idea that CNS changes produced by tissue 
damage and noxious inputs associated with surgery 
could contribute to postoperative pain has existed for 
several decades (Crile 1913). However, it was only after 




sound justification for pre-emptive treatment that this 
idea began to receive the clinical attention it deserves. 
Woolf and Wall (1986a) demonstrated in experimental 
animals that opioids are much more effective at reduc-
ing stimulus-induced increases in the excitability of the 
dorsal horn if they are administered prior to, rather 
than following, C-fiber electrical nerve stimulation. Re-
cent clinical evidence supports the hypothesis ~that the 
administration of analgesic agents prior to surgery may 
prevent the central sensitizing effects of the surgical 
procedure. In this manner it may be possible to reduce 
postoperative pain intensity or lower postoperative 
analgesic requirements for periods much longer than 
the duration of action of the pre-operatively adminis-
tered agents. 
In a recent issue of this journal, with a lead editorial 
on postoperative pain prevention by Wall (1988), Mc-
Quay et al. (1988) examined the possible prophylactic 
effect of opiate premedication and/or local anesthetic 
nerve blocks on postop~rative pain. They provided data 
showing that the time to first request for postoperative 
analgesics was longest among patients who had re-
ceived a pre-surgical treatment with opiates and nerve 
blocks, and shortest among patients who had received 
neither. Similar findings have recently been reported 
by Kiss and Kilian (1992) who showed that opiate 
pretreatment increased the length of time until request 
for first analgesic, reduced the percentage of patients 
requesting analgesics, and decreased analgesic con-
sumption in the first 48 h for patients undergoing 
lumbar disc surgery. Over the past few years, addi-
tional evidence has accumulated to support the hy-
pothesis that pre-emptive analgesia using a variety of 
agents (e.g., opiates, local anesthetics, NSAIDs) pro-
longs the time to first request for analgesics, reduces 
postoperative pain intensity, or decreases postoperative 
analgesic requirements among patients undergoing in-
guinal herniorraphy (Bugedo et al. 1990; Tverskoy et 
al. 1990), oral surgery (Tuffin et al. 1989; Hutchison et 
al. 1990; Campbell et a1. 1991), tonsillectomy (Agren et 
al. 1989; Jebeles et al. 1991), abdominal surgery 
(Mogensen et al. 1992), orthopedic surgery (Ringrose 
and Cross 1984; McGlew et al. 1991), lower limb ampu-
tation (Mann and Bisset 1983; Bach et al. 1988) and 
thoracotomy (Katz et al. 1992b). 
Tverskoy et al. (1990) clearly demonstrated the ben-
efits of pre-incisional blockade on postoperative pain. 
Patients who were undergoing inguinal herniorraphy 
received either general anesthesia alone, general anes-
thesia plus subcutaneous and intramuscular injections 
of bupivacaine prior to surgical incision, or spinal bupi-
vacaine administered pre-operatively. All patients re-
ceived the same regimen of postoperative analgesics. 
Twenty-four and 48 h after surgery, postoperative inci-
sional pain, movement-associated pain, and pain in-
duced by pressure applied to the surgical wound were 
all significantly lower in the two groups that had re-
ceived bupivacaine prior to surgical incision compared 
to patients that received general anesthesia alone. Sim-
ilar results were reported by Bugedo et al. (1990) who 
compared the effects of spinal lidocaine alone with 
spinal lidocaine plus ilioinguinal and iliohypogastric 
nerve blocks using bupivacaine prior to surgery in 
patients undergoing herniorraphy. The combination of 
spinal plus peripheral nerve blocks resulted in lower 
postoperative pain scores 24 and 48 h after surgery as 
well as reduced analgesic requirements during the first 
48 postoperative hours. 
Recently, a number of well-controlled, double-blind 
studies have also shown that pre-operative administra-
tion of NSAIDs by a variety of routes reduces postop-
erative pain long after the clinical duration of action of 
the NSAIDs. Campbell ct al. (1990) found that intra-
venous diclofenac administered before tooth extraction 
resulted in less postoperative pain the day after surgery 
when compared with pretreatment using intravenous 
fentanyl or a placebo. Similarly, Hutchison et a1. (1990) 
reported that compared to patients pre-treated with a 
placebo, significantly fewer patient who received orally 
administered prioxicam before tooth extraction re-
quired supplemental postoperative analgesics, and their 
time to first postoperative analgesic request was longer. 
McGlew et al. (991) demonstrated that on days 1-3 
after spinal surgery, postoperative pain scores and opi-
ate consumption were significantly lower among pa-
tients who had received indomethacin suppositories 
compared with placebo suppositories 1 h before 
surgery. 
Taken together, these studies demonstrate that opi-
ate premedication, regional local anesthesia, spinal 
anesthesia, or systemic NSAIDs administered before 
incision are more effective than placebo or no treat-
ment controls. The implication of these studies for 
clinical pathological pain is that changes in central 
neural function that are induced by surgery alter subse-
quent perception in such a way that nociceptive inputs 
from the surgical wound may be perceived as more 
painful (hyperalgesia) than they would otherwise have 
been, and innocuous inputs may give rise to frank pain 
(allodynia). 
However, these early studies on the prevention of 
postoperative pain with pre-operative analgesics did 
not compare the pretreatment with the effects of the 
same treatments administered after surgery (McQuay 
1992). Demonstrating that pretreatment with anal-
gesics, but not a placebo, lessens pain and decreases 
postoperative analgesic requirements at a time when 
the agents are no longer clinically active indicates that 
the central component of postoperative pain can be 
prevented or pre-empted. In the absence of a postinci-
sional or postoperative treatment condition, it is not 
possible to determine the separate contributions of 
factors associated with the intra-operative versus the 
postoperative period to the enhanced postoperative 
pain experience. It may be that analgesic pretreat-
ments reduce the development of local inflammation, a 
potential peripheral factor that could contribute to 
postoperative pain, rather than inhibiting central sensi-
tization induced by noxious inputs during surgery. This 
may be particularly important in the case of NSAIDs 
(Campbell et a1. 1990; Hutchison et al. 1990; McGlew 
et a1. 1991) which act primarily to reduce peripheral 
inflammation, but may also be important in the case of 
infiltration with local anesthetics (Bugedo et a1. 1990; 
Tverskoy et al. 1990) since local anesthesia would also 
reduce peripheral inflammation that is dependent on 
the efferent functions of peripheral nerves (i.e., neuro-
genic inflammation). Altering the timing of administra-
tion of analgesic agents (Le., before or after incision vs. 
before or after surgery) may provide clues to the spe-
cific intra-operative (e.g., incision, wound retraction) or 
postoperative (e.g., inflammation) factors that con-
tribute to the central neural changes underlying the 
enhanced pain. 
Recently, studies have been directed at identifying 
specific intra- and postoperative factors that may con-
tribute to surgically induced postoperative pain and 
hyperalgesia by comparing the effects on postoperative 
pain of opiates or local anesthetic agents administered 
either before or after surgery (Rice et a1. 1990; Dahl et 
a1. 1992b; Dierking et aI. 1992; Ejlersen et aI. 1992; 
Katz et aL 1992b). Rice et al. (1990) found that the 
timing of a caudal block with bupivacaine relative to 
the start of surgery had no effect on postoperative pain 
in a pediatric population undergoing brief (30 min) 
ambulatory surgical procedures. Dierking et aL (1992) 
evaluated the effects of a local-anesthetic inguinal field 
block administered before or after inguinal herniorra-
phy on postoperative pain and analgesic consumption. 
They also found that the timing of the block relative to 
surgical trauma did not produce differences in postop-
erative pain or analgesic use. Similarly, Dahl et al. 
(1992b) reported that postoperative pain and analgesic 
consumption did not depend on whether a n-h contin-
uous infusion of epidural bupivacaine and morphine 
was started before incision or immediately after surgery, 
approximately 2.5 h later. 
In contrast, Ejlersen et al. (1992) reported that even 
though pre-incisional blockade was not associated with 
significantly less postoperative pain, fewer patients in 
the pre-incisional group, as opposed to a postincisional 
group, required supplemental postoperative analgesics, 
and their demand for analgesics was delayed. In addi-
tion, Katz et al. (1992b) recently demonstrated that 
pre-incisional treatment with epidural fentanyl in pa-
tients undergoing thoracotomy resulted in significantly 
lower visual analogue scale (VAS) pain scores 6 h after 
treatment when compared with a postincisional treat-
ment. The significant difference in pain intensity could 
not be explained by lingering plasma concentrations of 
fentanyl, which at the time of pain assessment were 
equally sub-therapeutic in both groups, or by patient-
controlled analgesia (PCA) morphine consumption, 
which until this point was virtually identical in both 
groups. Also, between 12 and 24 h after surgery, the 
control group self-administered more than twice the 
amount of PCA morphine than the experimental group, 
a finding that parallels the study by Woolf and Wall 
(1986a). 
Although these latter studies comparing pre- and 
postincisional or surgical analgesic treatments have 
been somewhat inconclusive, several clinical, method-
ological and theoretical issues have arisen which signif-
icantly affect the conclusions drawn from these studies. 
One issue concerns the use of systemic opioids at the 
time of induction of the general anesthetic prior to 
surgery, or the use of these agents intra-operatively, as 
the surgery is underway. The pre-operative administra-
tion of opioids (alfentanyl, fentanyl) to all patients, as 
one component of the general anesthetic technique, 
may provide a sufficient block of nociceptive inputs to 
prevent or attenuate the development of CNS sensiti-
zation in all patients and may contribute to the lack of 
a clinically significant difference in outcome between 
the pre- and post-treatment groups in the studies of 
Dierking et a1. (1992) and Dahl et a1. (1992b). We do 
not as yet know the minimum effective doses of pre-op-
eratively administered systemic opioids that signifi-
cantly attenuate or prevent the central consequences of 
noxious peri-operative events that may contribute to 
postoperative pain. However, we do know from animal 
studies (Woolf and Wall 1986a) that the dose of sys-
temic morphine required to abolish established noxious 
stimulus-induced central hyperexcitability is an order 
of magnitude greater than the pretreatment dose re-
quired to prevent these prolonged central changes. 
Until the effects of pre- and intra-operative narcotics 
on postoperative pain have been established, their ad-
ministration as part of the general anesthetic proce-
dure in clinical studies of pre-emptive analgesia will 
confound the main outcome measures that are as-
sessed (Katz et al. 1992a). 
A second issue concerns the trade off between 
achieving the clinical objective of abolishing postopera-
tive pain and demonstrating specifically that the trauma 
associated with surgery may have a prolonged effect on 
postoperative pain. These two objectives run at cross 
purposes, since in order to demonstrate the latter the 
former may be compromised. In the study by Dahl et 
a1. (1992b) described above, postoperative VAS pain 
scores at rest were near zero in both groups (i.e., the 
group treated before and after surgery as well as the 
group treated only after surgery), making it virtually 
impossible to demonstrate an advantage of pre- over 
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postoperative analgesic administration. The postopera-
tive regimen of epidural bupivacaine and morphine 
may have been so effective as to block all nociceptive 
activity at the spinal level. Use of a lower dosage, or 
the use of epidural PCA instead of a fixed high dosage, 
may have provided the opportunity for lasting effects 
of the surgical trauma to become evident. This issue as 
it relates to pre-emptive analgesia is not whether post-
operative pain can be abolished regardless of the tim-
ing of administration of analgesics relative to surgical 
incision, although abolishing postoperative pain is a 
clinical objective that we all should strive to achieve. 
When examining the efficacy of pre-emptive analgesia, 
patients must be able to demonstrate their level of pain 
either directly through verbal report (e.g., VAS pain 
scores) or indirectly, through their consumption of 
postoperative analgesics. 
Neurochemical mediators of noxious stimulus-induced 
plasticity 
The evidence presented above suggests that periph-
eral injuries are capable of producing changes in CNS 
function which in turn influence nociceptive process-
ing. We will now examine the mechanisms that may 
underlie the central neuroplasticity generated by nox-
ious stimulation or injury. Specifically, we will assess 
the contribution of C-fiber neuropeptides and excita-
tory amino acid (EAA) transmitters to noxious stimu-
lus-induced changes in central neural function. We will 
also evaluate the role of these transmitters in animal 
models of secondary hyperalgesia and persistent pain. 
C-fiber neuropeptides 
Several lines of evidence suggest that C-fiber neu-
ropeptides are involved in triggering CNS plasticity 
following injury or noxious stimulation. A role for 
C-fiber neuropeptides in nociception is suggested since 
noxious stimulation or peripheral inflammation causes 
the release of substance P (SP) (Go and Yaksh 1987; 
Oku et a1. 1987; Duggan et al. 1988), neurokinin A 
(Hua et al. 1986; Duggan et a1. 1990) somatostatin 
(Kuraishi et a1. 1985; Morton et al. 1988), calcitonin 
gene-related peptide (CGRP) (Saria et al. 1986) and 
galanin (Morton and Hutchison 1990) in spinal cord 
dorsal horn. There is also a decrease in immunoreac-
tive staining for the neuropeptides SP and CGRP in 
chronic pain models such as experimental arthritis 
(Sluka et al. 1992) and experimental peripheral neu-
ropathy (Bennett et al. 1989; Cameron et al. 1992). 
Furthermore, the iontophoretic application of SP and 
other neurokinins produces an excitation of dorsal 
horn neurons (Henry 1976; Willcockson et a\. I 984b ), 
while intrathecal treatment produces behavioral hyper-
algesia (Moochala and Sawynok 1984; Cridland and 
Henry 1986) or nociceptive behaviors (Hylden and 
Wilcox 1981; Seybold et at. 1982; Gamse and Saria 
1986) in rodents. 
A role of C-fiber neuropeptides in noxious 
stimulus-induced plasticity is suggested by several find-
ings. Repetitive stimulation of dorsal roots elicits a 
slow depolarization in dorsal horn neurons which is 
mimicked by SP (Murase and Randic 1984), neurokinin 
A (Murase et al. 1989), CGRP (Ryu et a\. 1988), 
vasoactive intestinal polypeptide (VIP) (Urban and 
Randic 1984) or cholecystokinin (CCK) (Murase et al. 
1987), and is blocked by SP antagonists or capsaicin 
applied to the tissue bath (Urban and Randic 1984). 
Iontophoretic application of neuropeptides, such as 
SP, produces enhanced dorsal horn neuron responses 
to noxious thermal and mechanical stimulation (Henry 
1976; Randic and Miletic 1977). The increased ex-
citability in flexor efferents. induced either by C-fiber 
electrical stimulation or by the application of chemical 
irritants, is blocked by pretreatment of the sciatic and 
saphenous nerves with the C-fiber neurotoxin capsaicin 
(Woolf and Wall 1986b) or by the SP antagonist span-
tide II (Wiesenfeld-Hallin et al. 1990). Intrathecal ap-
plication of the C-fiber neuropeptides SP (Woolf and 
Wiesenfeld-Hallin 1986). neurokinin A (Xu et al. 1991), 
CGRP (Woolf and Wiesenfeld-Hallin 1986), VIP (Wie-
senfeld-Hallin 1987), somatostatin (Wiesenfeld-Hallin 
1985) and galanin (Wiesenfeld-Hallin et a1. 1989) pro-
duces prolonged enhancements in the excitability of 
the flexion reflex. In addition, the hyperalgesia that 
develops in the hind paw contralateral to a thermal 
injury is mimicked by intrathecal treatment with SP 
and neurokinin A, and reversed by pretreatment with 
the SP antagonist. D-Argl, Pro 2 , D-Phe 2 , -D-His~-SP 
(Coderre and Melzack, 19(1). Subcutaneous injection 
of formalin, which elicits a persistent nociceptive re-
sponse associated with central changes (Coderre et al. 
1990), evokes an immediate, intense barrage of C-fiber 
afferent activity (Heapy et al. 1990), and produces an 
increase in SP in the cerebrospinal fluid (Kuraishi et 
a\. 1989). Furthermore, nociceptive responses to forma-
lin are significantly suppressed in rats pretreated with 
peptide (Murray et al. 1991) and non-peptide 
(Yamamoto and Yaksh 1991; Yashpal et a\. 1992) SP 
antagonists, as well as the C-fiber neurotoxin capsaicin 
and its non-pungent analogue olvanil (Dray and Dick-
enson 1991). 
Excitatory amino acids 
Additional evidence implicates a contribution of 
EAAs to injury-induced neurdplasticity. EAAs have 
widespread activity in the CNS including the spinal 
cord (Watkins and Evans 1981; Davies and Watkins 
1983) and thalamus (Eaton and Salt 1990). The role of 
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EAAs in nociception is suggested since noxious stimu-
lation or peripheral inflammation causes the release of 
glutamate and aspartate in spinal cord dorsal horn 
(Skilling et al. 1988; Sorkin et aI. 1992). Furthermore, 
iontophoretic application of EAAs produces an excita-
tion of dorsal horn neurons (Curtis and Watkins 1960; 
Willcoxson et al. 1984a; Schnieder and Perl 1988), 
while intrathecal treatment produces both behavioral 
hyperalgesia and spontaneous nociceptive behaviors 
(Aanonsen and Wilcox 1986, 1987). 
A role of EAAs in noxious stimulus-induced plastic-
ity is suggested by several findings. Repetitive C-fiber 
stimulation produces a 'wind-up' of dorsal hom neuron 
activity which is mimicked by the application of L-
glutamate or NMDA (Gerber and Randic 1989; King 
et ai. 1989), and blocked by application of either com-
petitive (Dickenson and Sullivan 1987a; Thompson et 
a!. 1990) or non-competitive (Davies and Lodge 1987; 
Thompson et al. 1990) NMDA antagonists. Ion-
tophoretic application of EAAs produces receptive field 
changes in dorsal horn neurons (Zieglgansberger and 
Herz 1970, as well as enhanced dorsal horn neuron 
responses to non-noxious and noxious mechanical stim-
ulation (Aanonsen et al. 1990; Dougherty and Willis 
1991b). Dorsal hom neurons which are sensitized fol-
lowing peripheral tissue injury/inflammation show in-
creased responsiveness to the iontophoretic application 
of EAAs (Dougherty and Willis 1992; Dougherty et at. 
1992c), and exhibit a reduction in responsiveness or 
sensitization following intravenous administration of 
ketamine or iontophoretic application of ketamine or 
2-amino-5-phosphonopentanoic acid (AP-S) (Schaible 
et al. 1991), or the administration of CNQX or 2-
amino-7 -phosphonoheptanoic acid (AP-7) to dorsal 
horn neurons by microdialysis (Dougherty et at. 1992b). 
Intrathecal administration of the EAAs L-glutamate or 
L-aspartate produces an increase in the excitability of 
flexor efferents (Woolf and Wiesenfeld-HaIIin 1986), 
while competitive or non-competitve NMDA antago-
nists reduce the facilitation of flexion reflexes induced 
by electrical (C-fiber) stimulation or cutaneous applica-
tion of the chemical irritant mustard oil (Woolf and 
Thompson 1991). Hyperalgesia that develops in the 
hind paw contralateral to a thermal injury is both 
mimicked following intrathecal treatment with NMDA, 
and reversed by the NMDA receptor antagonist (AP-S) 
(Coderre and Melzack 1991). In a recent study in 
humans (Gordh and Kristensen 1992), it has been 
shown that intrathecal treatment with the competitive 
NMDA receptor antagonist CPP abolished afterdis-
charges and spreading pain and hyperalgesia (symp-
toms proposed to be associated with windup) in a 
patient with neuropathic pain. 
NMDA antagonists have been particularly effective . 
at reducing persistent pain associated with central sen-
sitization. The non-competitive NMDA antagonist 
MK-801 reduces the hyperalgesia which develops in 
rats with peripheral neuropathy (Davar et al. 1991; 
Mao et a!. 1992b) or adjuvant-induced inflammation 
(Ren et at. 1992) and reduces autotomy behavior in 
rats with peripheral nerve sections (Seltzer et a!. 1991b). 
MK-801 also reduces the adjuvant inflammation-in-
duced expansion of the receptive fields of nociceptive 
neurons in spinal cord dorsal hom (Dubner and Ruda 
1992). In humans, ischemic and postoperative pain is 
suppressed by subanesthetic doses of ketamine (Maur-
set et a1. 1989), while in the rat, the increased activity 
in dorsal hom in response to ischemia associated with 
femoral artery occlusion is inhibited by intrathecal 
application of AP-5 (Sher and Mitchell 1990). Subcuta-
neous injection of formalin evokes an increased release 
of glutamate and aspartate in spinal cord dorsal horn 
(Skilling et aJ. 1988), while the sustained responses of 
spinal nociceptive cells to noxious peripheral stimula-
tion produced by subcutaneous formalin injection are 
reduced by intrathecal administration of selective 
NMDA antagonists (Haley et at. 1990). Nociceptive 
responses to formalin are also both enhanced by pre-
treatment with the EAA agonists, L-glutamate and 
L-aspartate, as well as combinations of NMDA + 
AMPA or NMDA + trans-ACPD (Coderre and 
Melzack 1992a), and suppressed by pretreatment with 
the NMDA antagonists AP-5 or MK-801 (Murray et al. 
1991; Coderre and Melzack 1992a). 
Interaction of neuropeptides and excitatory amino acids 
An interaction of neuropeptides and EAAs in cen· 
tral nociceptive processing is also suggested by several 
findings. Neuropeptides and EAAs are found to be 
co-localized in the central terminals of primary affer-
ent neurons (DeBiasi and Rustioni 1988). SP produces 
a prolonged enhancement of the responses of dorsal 
horn neurons to ionotophoretically applied glutamate 
(Willcockson et aI. 1984b) or NMDA (Dougherty and 
Willis 1991 a). Combined treatment with SP and NMDA 
produces a profound enhancement of the responses of 
dorsal horn neurons to non-noxious and noxious me· 
chanical stimulation (Dougherty and Willis 1991a), as 
well as the behavioral responses to noxious chemical 
stimulation (Mjellem-Joly et al. 1992). These effects 
likely depend on both pre-synaptic and postsynaptic 
actions of neuropeptides on EAA neurotransmission 
since SP, neurokinin A or CGRP have been found to 
enhance the release of glutamate and aspartate from 
spinal cord dorsal horn (Kangrga and Randic 1990; 
Smullin et al. 1990), while SP produces a potentiation 
of glutamate- and NMDA-induced currents in rat spinal 
dorsal hom neurons in vitro (Randic et at. 1990). 
Recent evidence also indicates that the amount of SP 
required to increase EAA release is reduced in rats 
with peripheral neuropathy following partial sciatic 
nerve ligation (Skilling et at. 1992a). 
--- --------------------------------------------------------------
Cellular mechanisms of noxious stimulus-induced 
plasticity 
The above data suggest that both neuropeptides and 
EAAs may contribute to CNS neuroplasticity affecting 
nociceptive behavior. However, the manner by which 
these substances produce these central changes is not 
clear. It is possible that neuropeptides and EAAs trig-
ger alterations in membrane excitability through inter-
actions with second messenger systems and protein 
kinases which phosphorylate membrane-bound pro-
teins (Nestler and Greengard 1983). Evidence suggests 
that there is a contribution of intracellular calcium 
(Ca2+), second messenger systems and protein kinases 
to the development of noxious stimulus-induced neuro-
plasticity. 
Intracellular calcium 
Recent evidence suggests that noxious stimulation 
may produce an increase of intracellular Ca2+ in noci-
ceptive neurons which influences the excitability of the 
cell. Neurotransmitters released in response to noxious 
stimulation are known to affect the intracellular levels 
of Ca2 +. Glutamate and aspartate stimulate the influx 
of Ca2+ through NMDA receptor-operated channels 
(MacDermott et al. 1986). SP produces an elevation in 
intracellular Ca2 + by mobilizing its release from intra-
cellular stores (Womack et al. 1988), while both SP 
(Womack et al. 1989) and CGRP (Oku et al. 1988) 
increase Ca2+ influx through voltage-gated Ca2+ chan-
nels. 
Studies assessing the behavioral effects of agents 
affecting calcium availability suggest that Ca2 +influx is 
more critical in persistent pain models where central 
sensitization and plasticity are present. These studies 
indicate that brief, phasic nociceptive tests, such as the 
tail-flick and hot-plate tests, are unaffected by Ca2 + 
(Harris et al. 1975; Chapman and Way 1982), Ca2+ 
chelators (Harris et al. 1975; Ben-Sreti et al. 1983), or 
Ca2+ channel antagonists (Benedek and Sikszay 1984; 
Contreras et al. 1988), while tonic nociceptive tests, 
such as the formalin and acetic acid-induced writhing 
tests, are sensitive to Ca2 +, Ca2+ ionophores and Ca2 + 
channel agonists (Chapman and Way 1982; Coderre 
and Melzack 1992b) which increase nociceptive re-
sponses, or Ca2 + chelators and Ca2 + channel antago-
nists (Del Pozo et al. 1987; Coderre and Melzack 
1992b; Miranda et al. 1992) which reduce nociceptive 
responses. 
While the behavioral effects of agents affecting Ca2 + 
availability may depend, in part, on the effect of Ca2+ 
influx on presynaptic transmitter release (Rubin 1974), 
it is possible that their effects may also depend on 
Ca2+ influx in the postsynaptic cell. Although nocicep-
tive responses to formalin are significantly suppressed 
by intrathecal administration of voltage-gated Ca2 + 
channel antagonists, they are more effectively sup-
pressed by Ca2 + chelators which reduce all available 
extracellular Ca2 + (not just that which enters through 
voltage-gated Ca2+ channels), and by non-competitive 
NMDA antagonists which block Ca2+ influx through 
NMDA receptor-operated Ca2+ channels. Further-
more, the enhancement of nociceptive responses to 
formalin injury following intrathecal treatment with 
L-aspartate or L-glutamate is prevented by agents 
which block NMDA receptor-operated Ca2+ channels, 
but not by those which block voltage-gated calcium 
channels (Coderre and Melzack 1992b). These data 
suggest the development of persistent nociception after 
formalin injury is influenced by the influx of Ca2 + into 
postsynaptic cells, particularly through NMDA recep-
tor-operated channels (MacDermott et al. 1986). 
Intracellular second messengers 
Recent evidence also implies that noxious stimulus-
induced plasticity may depend, in part, on the phos-
pholipase C (PLC) second messenger system. Activity 
at either NK-l receptors by SP (Mantyh et al. 1984), or 
at metabotropic EAA receptors by glutamate and as-
partate (Sugiyama et al. 1987), stimulates the hydrolysis 
of inositol phospholipids by activating a polyphospho-
inositide-specific PLC. PLC is an enzyme which cat-
alyzes the hydrolysis of polyphosphatidylinositol into 
the intracellular messengers inositol trisphosphate OP,) 
and diacylglycerol (DAG). It has recently been sho~n 
that neomycin (an agent which inhibits PLC activity) 
produces a substantial reduction in nociceptive re-
sponses during the formalin test (Coderre 1992). Since 
inhibition of PLC with neomycin produces a significant 
reduction in formalin nociceptive responses, it is as-
sumed that IP, and DAG play a significant role in 
formalin-induced plasticity, Following its production, 
IP3 stimulates the release of Ca2 + from internal stores; 
on the other hand DAG stimulates the translocation 
and activation of protein kinase C (PKC). When acti-
vated by DAG, PKC phosphorylates specific substrate 
proteins that contribute to various cellular processes, 
including neurotransmitter release and transduction 
(Nishizuka 1986). Stimulation of PKC with phorbol 
esters and synthetic DAG, or the intracellular microin-
jection of PKC, has been found to enhance Ca2 + 
currents (DeRiemer et al. 1985), which may increase 
neuronal excitability as well as presynaptic transmitter 
release, and to reduce both Ca2+-dependent K+ cur-
rents (Alkon et al. 1986) and CI- currents (Madisonet 
al. 1986), which may result in the prolongation of 
depolarization and after discharges associated with an 
inhibition of spike accommodation. 
Recently, Gerber et al. (1989) have shown that acti-
vators of PKC enhance the basal and evoked release of 
glutamate and aspartate in the spinal cord slice, as weIl 
as the depolarizing responses of dorsal horn neurons to 
exogenous glutamate and NMDA. Furthermore, Chen 
and Huang (1992) have demonstrated that PKC in-
creases NMDA-activated currents in isolated trigemi-
nal cells by increasing the probability of channel open-
ings and by reducing the voltage-dependent Mg2+ block 
of NMDA-receptor channels. The resultant increased 
activity at the NMDA receptor would permit more 
Ca2 + ions to enter the cell, raising intracellular ea2 +, 
and so further increasing PKC activity, and its effects 
on NMDA receptor channels. This positive feedback 
loop may be important for the induction or mainte-
nance of sensitization in central neurons. 
It has been shown recently that the activation of 
metabotropic EAA receptors with quisqualate or 
trans-ACPD produces an enhancement of NMDA cur-
rents in both hippocampal neurons (Anikstejn et al. 
1991; Ben-Ari et al. 1992) and oocytes injected with rat 
brain RNA (Kelso et a1. 1992). Furthermore, since in 
both these studies the effects of metabotropic EAA 
receptor activation were blocked by PKC inhibitors, it 
is likely that activity at the metabotropic receptor en-
hances NMDA currents by stimulating intraceIlular 
PKC. 
Recent behavioral studies (Coderre 1992), indicate 
that nociceptive responses to formalin injury are sup-
pressed following intrathecal treatment with H-7 which 
inhibits PKC, and enhanced after treatment with phor-
bol esters or SC-lO which stimulate PKC. These results 
are consistent with a contribution of PKC to the persis-
tent nociceptive response elicited by subcutaneous in-
jection of fonnalin. A contribution of PKC to noxious 
stimulus-induced plasticity is consistent with its estab-
lished role in long-term potentiation (Malenka et a1. 
1986; Hu et al. 1987). Furthermore, a contribution of 
PKC to persistent pain is consistent with the findings 
of Hayes et a1. (1992) who demonstrated that 
monosialoganglioside, which inhibits the translocation 
of PKC (Vaccarino et al. 1987), reduces behavioral 
hyperalgesia in rats with peripheral neuropathy. 
Molecular mechanisms of noxious stimulus-induced 
plasticity 
In addition to altering membrane permeability, in-
creases in intracellular Ca2 + and the activation of PKC 
result in the increased expression of proto-oncogenes 
such as c-fos. The protein products of these proto-
oncogenes act as third messengers which are believed 
to be involved in the transcriptional control of genes 
that encode a variety of neuropeptides, including 
enkephalins and tachykinins. 
Expression of c-fos and other proto-oncogenes 
Noxious stimulation leads to the expression of 
proto-oncogenes and their protein products. Hunt et 
al. (1987) first demonstrated that the c-fos protein 
product Fos is expressed in postsynaptic dorsal horn 
neurons following noxious thermal or chemical stimula-
tion of the skin. The expression of Fos has also been 
demonstrated in rat spinal dorsal horn in response to 
noxious pinch of the hind paws (Bullitt 1989), the 
injection of formalin (Presley et al. 1990; Kehl et al. 
1991) or carageenan (Draisci and Iadorola 1989) into a 
hind paw or sodium urate crystals into joints (Menetrey 
et al. 1989), the injection of acetic acid into viscera 
(Menetrey et al. 1989), the induction of poly-arthritis 
with Freund's adjuvant (Menetrey et al. 1989), and the 
development of a neuroma following nerve injury (Chi 
et al. 1990). Noxious stimulation also leads to the 
spinal cord expression of other proto-oncogenes prod-
ucts, including Fos B, Jun, Jun B, Jun D, NGFI-A, 
NGFI-B and SRF (Herdegen et al. 1990a,b; Wisden et 
al. 1990; Herdegen et al. 1991a-c). Furthermore, fol-
lowing noxious stimulation there is an increased ex-
pression of Fos in CNS structures involved in pain 
transmission, including the periaqueductal grey, thala-
mus, habenula and somatosensory cortex (Bullit 1989; 
Iadorola et al. 1990; Herdegen et al. 1991b). Impor-
tantly, there is a strong correlation between pain be-
havior and the number of cells expressing Fos (Presley 
et a1. 1990). Moreover, morphine pretreatment pro-
duces a dose-dependent suppression of Fos expression 
which corresponds with its analgesic effects (Presley et 
a1. 1990; Tolle et al. 1991). 
Relationship between c-fos, central neuroplasticity and 
hyperalgesia 
Although there is evidence that noxious stimulation 
leads to the expression of Fos, this does not necessarily 
mean that c-fos is involved in central plasticity associ-
ated with hyperalgesia. However, there is growing evi-
dence of a relationship between noxious stimulus-in-
duced Fos expression, central neuroplasticity and be-
havioral hyperalgesia. First, the noxious stimuli that 
produce Fos expression (heat injury, formalin injection 
and inflammatory agents) also produce behavioral hy-
peralgesia which is associated with central neuroplas-
ticity (Coderre and Melzack 1985, 1987; Kayser and 
Guilbaud 1987; Coderre et al. 1990). Second, the time 
course of Fos expression coincides with the develop-
ment of behavioral hyperalgesia. This co-occurrence is 
evident in cases where noxious inputs are driven by a 
specific peripheral lesion. For example, peripheral in-
flammation induced by carrageenan produces both an 
increase in c-fos mRNA and behavioral hyperalgesia 
that peak over a similar time course (Draisci and 
Iadorola 1989). 
However, the co-occurrence of Fos expression and 
behavioral hyperalgesia is also evident in cases where a 
peripheral stimulus initiates but does not apparently 
maintain the hyperalgesia. Thus, heat injury of a rat's 
hind paw produces an immediate hyperalgesia in the 
injured hind paw and hyperalgesia in the uninjured 
contralateral hind paw which develops between 4 and 
24 h after injury (Coderre and Melzack 1985, 1991). 
Similarly, heat injury of a rat's hind paw, or C-fiber 
stimulation of the sciatic nerve, not only produces an 
immediate expression of Fos in the spinal cord dorsal 
horn ipsilateral to the injury, but also produces a 
'second wave' of Fos (Williams et al. 1990) Jun 
(Herdegen et al. 1991a), Jun 0 (Herdegen et al. 1991c) 
and NGFIA (Herdegen et al. 1990b) activity in both 
ipsilateral and contralateral dorsal horns 4-24 h after 
the injury. An association of the behavioral hyperalge-
sia and Fos expression with neural plasticity after heat 
injury is suggested since both the contralateral hyperal-
gesia (Coderre and Melzack 1987) and the Fos expres-
sion in the contralateral dorsal horn (Williams et al. 
(990) still develop when the injured hind limb is locally 
anesthetized shortly after the injury. Furthermore, 
Herdegen et al. (1990a) have shown that while 'low-
level' noxious cutaneous stimulation of one hind paw 
induced Fos in only a few neurons, the same stimulus 
repeated 1 h later in the contralateral hind paw in-
duced dense Fos labelling in many neurons. The 'sec-
ond wave' expression of proto-oncogenes in the con-
tralateral dorsal horn, and the enhanced expression of 
Fos if there has been prior noxious stimulation of the 
contralateral hind paw, are consistent with the idea 
that central sensitization results in the spread of hyper-
algesia to a limb contralateral to a heat injury. Interest-
ingly, while heat injury of a rat's hind paw leads to the 
development of both contralateral hyperalgesia and a 
'second wave' of proto-oncogenes products in the con-
tralateral dorsal horn, inflammatory lesions with for-
malin (Coderre et al. 1990) or carrageenan (Hargreaves 
et al. 1988) produce minimal contralateral behavioral 
responses and little or no proto-oncogene activity in 
the contralateral dorsal horn (Williams et al. 1990; 
Herdegen et al. 1991c, Noguchi et a1. 1991, 1992). 
Triggers of c-fos gene expression 
Since an elevation of intracellular Ca2 + is crucial to 
the transcriptional activation of the c-fos proto-onco-
gene (Morgan and Curran 1986), it is possible that 
c{os is induced in spinal cord dorsal horn following 
Ca2 + entry through NMDA receptor-operated Caz+ 
channels, or through voltage-gated Ca2 + channels fol-
lowing the activation of other receptors, such as the 
NK-l receptor by SP. Indeed, NMDA receptor activa-
tion with glutamate or NMDA leads to increases in 
c-fos mRNA or Fos protein in rat cerebellar granule 
cells (Szekely et al. 1989), dentate gyrus (Lerea et al. 
1992) and cortical neurons (Hisanaga et al. 1992) in 
culture. Furthermore, the effect of glutamate is blocked 
by competitive or non-competitive NMDA receptor 
antagonists, or by Mg2+ which blocks NMDA-recep-
tor-operated Ca2+ channels (Szekely et al. 1989; 
Hisanaga et al. 1992). Although c-fos activity can also 
be elevated by increasing Ca2 + availability with the 
Ca2 + ionophore ionomycin (Szekely et al. 1989) or 
reduced by the chelation of extracellular Ca2 + with 
EGT A (Lerea et al. 1992), the importance of NMDA-
receptor operated Ca2 + channels is indicated by the 
finding that the glutamate or NMDA-induced increase 
in c{os expression is unaffected by nifedipine or ni-
trendipine, selective blockers of voltage-gated Ca2+ 
channels (Szekely et al. 1989; Lerea et al. 1992). 
While it has been demonstrated that noxious stimu-
lation-induced expression of Fos in the spinal dorsal 
horn is substantially reduced by pretreatment with the 
NMDA receptor antagonist MK-801 (Kehl et al. 1991; 
Birder and de Groat 1992), others have found that 
NMDA antagonists do not affect the distribution of 
Fos-Iabelled neurons in spinal cord (Wisden et al. 
1990; Tolle et at 199 L). This discrepancy may depend 
on differences in the nature of the noxious stimulus 
applied to the periphery (chemical vs. thermal stimula-
tion), or specific differences in experimental methods, 
such as the type of anesthetic agent used. 
Recently, Lerea et al. (1992) have demonstrated that 
c-fos mRNA is also induced in dentate gyrus neurons 
following the activation of kainate / AMP A receptors 
with kainic acid. While both NMDA- and kainic acid-
induced c-fos expression was eliminated by chelation of 
extracellular Ca2 + with EGTA, only kainic acid-in-
duced c{os expression was reduced with the voltage-
gated Ca2 + channel blocker nifedipine. These findings 
suggest that c-fos induction depends on increases in 
intracellular Ca2 + that results due to an influx of Ca2 + 
through either NMDA receptor-operated Ca2+ chan-
nels after NMDA receptor activation, or through volt-
age-gated Ca2 + channels after activation of non-
NMDA EAA receptors. 
There is also an increase in the expression of Fos 
protein in spinal cord neurons in response to SP (Bigot 
et al. 1991), and increase in c-fos mRNA in cerebellar 
granule cells in response to non-NMDA EAA receptor 
agonists (Szekely et al. 1987), such as quisqualate. Both 
SP and quisqualate act at metabotropic receptor sites 
to stimulate the second messengers IP1 and DAG 
following the activation of PLC (Sugiyam~ et al. 1987). 
Furthermore, c{os expression is also induced in cul-
tures of neuronal cells (Naranjo et al. 1991) by stimula-
tion of PKC with phorbol esters or DAG. Interestingly, 
the ability of quisqualate to induce the expression of 
c-fos in cerebral granule cells is lost when Mg2 + is 
added to block NMDA receptor-operated Ca2 + chan-
nels (Szekely et al. 1989). This suggests that the expres-
sion of c{os depends on an interaction between Ca2 + 
influx through NMDA receptor-operated Ca2+ chan-
nels and the stimulation of second messengers, such as 
DAG, which are linked to metabotropic receptors and 
activate PKC (Nishizuka, 1986). Perhaps this is not 
surprising, since the DAG-induced translocation and 
activation of PKC depends on an accompanying Ca2+ 
influx (see Rasmussen 1986). Thus, it is possible that 
the expression of early immediate genes, such as clos, 
is induced by Ca2+ influx and the translocation and 
stimulation of PKC, following the activation of both 
NMDA and non-NMDA EAA receptors or other 
metabotropic receptors, such as the NK-1 (SP) recep-
tor, which by activating PLC stimulate the production 
ofDAG. 
Consequences of c-fos expression 
We know that c-fos is expressed in response to 
noxious stimulation, and may be triggered by an EAA-
and/or a neuropeptide-induced influx of ea2+ and 
activation of PKC, but what is the significance of its 
expression to the development of noxious stimulus-in-
duced plasticity or hyperalgesia? Early immediate genes 
are thought to code for transcription factors controlling 
the expression of downstream genes. The Fos protein 
forms a heterodimer with Jun which binds to AP-1-like 
elements to form a DNA binding site in the promoter 
region of its target gene (Morgan and Curran, 1989). 
There is evidence to suggest that c-fos participates 
in the regulation of mRNA encoding various peptides 
in the rat spinal cord. Peripheral inflammation, trigem-
inal nerve stimulation or nerve lesions result in the 
increase in the expression of mRNA encoding dynor-
phin (HoUt et at. 1987; Ruda et al. 1988), enkephalin 
Oadorola et al. 1988; Nishimori et al. 1989), SP 
(Noguchi et at. 1988; Minami et al. 1989) and CGRP 
(Piehl et al. 1991) in the dorsal root ganglion, dorsal 
horn or the nucleus caudalis. Furthermore, there is 
strong evidence suggesting that the preprodynorphin 
and preproenkephalin genes are targets for c-fos. Thus, 
the increase in Fos protein which peaks 2 h after 
peripheral inflammation is followed by a modest in-
crease in preproenkephalin mRNA and a large in-
crease in preprodynorphin mRNA, each peaking at 3 
days Oadorola et al. 1988). While the noxious 
stimulus-induced increase in preprodynorphin mRNA 
is followed by a subsequent increase in dynorphin 
peptide (Iadorola et at. 1988; Weihe et a1. 1989), the 
increased preproenkephalin mRNA does not produce 
measurable increases in enkephalin peptide (Iadorola 
et a!. 1988). In addition, following peripheral inflam-
mation, Fos protein-like immunoreactive (Fos-IR) neu-
rons are found to co-localize with neurons expressing 
either preprodynorphin or preproenkephalin mRNA 
(Noguchi et at. 1991; 1992). Over 80% of the neurons 
in the superficial laminae and the neck of the dorsal 
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horn which express preprodynorphin or prepro-
enkephalin co-localize Fos-IR. The high percentage of 
preprodynorphin and preproenkephalin mRNA co-
localized with Fos-IR has been taken as evidence that 
Fos phosphoprotein signalling is coupled to dynorphin 
and enkephalin gene transcription (Dubner and Ruda 
1992). It has also been shown that phorbol esters, 
which activate PKC, lead to an induction of c-fos 
mRNA (within 30 min) and a later increase in the level 
of preprodynorphin mRNA (between 1.5 and 6 h) in 
neuronal cells in culture (Naranjo et at. 1991). Further-
more, it has been recently shown that Fos and lun 
proteins bind to fonn an AP-1-like site in the promoter 
regions of the rat preprodynorphin (Naranjo et a!. 
1991) and preproenkephalin (Sonnenberg et al. 1989) 
genes. 
If clos is involved in the transcriptional control of 
the dynorphin and enkephalin genes, and its expression 
following noxious stimulation leads to an increased 
synthesis of dynorphin and perhaps enkephalin, what is 
the significance of dynorphin and enkephalin to nox-
ious stimulus-induced plasticity and hyperalgesia? 
Enkephalin and other delta opioid agonists typically 
produce inhibitory or antinociceptive effects (Vaught 
et a1. 1982), and may provide a mechanisms by which 
central plasticity and hyperalgesia is minimized 
(Dubner 1991). On the other hand, while dynorphin 
and other kappa opioids are typically found to produce 
moderate antinociceptive effects (Hayes et a!. 1987; 
Millan and Colpaert 1991), they have dual effects in 
the spinal cord dorsal horn (Knox and Dickenson, 
1987; Hylden et at. 1990. Dynorphin, in particular, has 
been found to produce expanded receptive fields and a 
facilitation of the responses of approximately one-third 
of superficial dorsal horn cells, while producing an 
inhibition of responses in another third of the cells 
(Hylden et al. 1991). It has been suggested that while 
dynorphin may produce direct excitatory effects on 
spinal projection neurons, it may also produce inhibi-
tion by a negative feedback mechanism on dynorphin-
containing neurons (Dubner and Ruda 1992). In this 
way, dynorphin may have complex effects modulating 
the development of central plasticity and hyperalgesia 
in various ways. 
Pain and neuroplasticity: a developing theory 
The idea that injury or noxious stimulation can 
produce alterations in CNS function affecting pain 
sensitivity is not a new one. Sturge (1883) proposed 
that peripheral injury triggers a change in the excitabil-
ity of the CNS so that nonnal inputs evoke exaggerated 
responses leading to pain hypersensitivity. MacKenzie 
(1893) suggested that increased pain sensitivity and 
referred pain could be the result of increased sensitiv-
ity of CNS structures. He proposed that sensory im-
pulses arising from injured tissues create an 'irritable 
focus' in spinal cord segments onto which they im-
pinge. In relation to peri-operative anesthesia, Crile 
(1913) wrote that patients given inhalational anesthesia 
still need to be protected by regional anesthesia; other-
wise they might incur persistent CNS changes and 
enhanced postoperative pain. According to Hardy et 
al. (950), secondary hyperalgesia and referred cuta-
neous hyperalgesia occur because an injury produces a 
state of hyperexcitability in the spinal cord. This hyper-
excitability is sustained following the activation of a 
network of internuncial neurons, which produces a 
spreading facilitation of adjacent neurons in the spinal 
cord, allowing for the spread of hyperalgesia to unin-
jured regions of the body. In reference to deafferenta-
tion pain, Livingston (1943) suggested that the afferent 
activity generated by injured peripheral nerves elicits 
an abnormal firing pattern within the spinal cord. He 
proposed that a disturbance occurs in an internuncial 
pool of dorsal horn interneurons and results in rever-
beratory activity which eventually spreads to other parts 
of the spinal cord, including areas that affect the 
sympathetic chain. Increased activity in sympathetic 
efferents would disrupt vasoreguiation and induce fur-
ther hypersensitivity of peripheral tissue, leading to 
increased afferent input and a 'vicious-circle' of pe-
ripheral-central activity. 
Aside from descriptive references to irritable foci, 
reverberatory activity and vicious circles, the above 
theories do not provide empiral evidence for, or details 
of, the nature of the CNS changes that occur following 
noxious stimulation. Only recently has there been spe-
cific empirical evidence indicating noxious stimulus-in-
duced changes in CNS function. The studies of Perl 
(1976) and Kenshalo et al. (1979) were the first to 
demonstrate that noxious peripheral stimuli do pro-
duce changes in the sensitivity of dorsal horn neurons 
to further stimulation; while Woolf and Wall (Woolf 
1983; Woolf and Wall 1986a) were the first to provide 
empirical evidence for a primary afferent input trigger-
ing sustained increases in central excitability. Woolf 
(1983) demonstrated that injury-induced increases in 
spinal cord excitability could be maintained even after 
local anesthesia of the injured site, providing empirical 
evidence that acute injury could produce lasting spinal 
changes. Woolf and Wall (1986a) showed that the 
amount of morphine required to prevent the develop-
ment of this spinal hyperexcitability was IO-fold less 
than the amount required to reverse it after it was 
established, and provided the experimental basis for 
subsequent clinical investigations of the use of pre-
emptive analgesia for the prevention or alleviation of 
postoperative pain. 
The recent experimental literature of Woolf, Wall 
and others, described in earlier sections of this paper, 
indicates that noxious stimulation or lTIjury can pro-
duce dramatic alterations in spinal cord function, in-
cluding sensitization, wind-up or the expansion of the 
receptive fields of spinal neurons. Recently, several 
investigators have proposed detailed theories of how 
noxious stimuli produce these changes in CNS func-
tion. Woolf (1991) proposed that the release of EAAs 
and C-fiber neuropeptides produces slow depolariza-
tions leading to both cellular and molecular changes 
which alter membrane properties. Thus, inputs arriving 
from small diameter primary afferents lead to the 
release of EAAs and neuropeptides within the spinal 
cord dorsal horn. EAAs acting at non-NMDA recep-
tors produce a fast excitatory postsynaptic potential, 
but it is not until a slow synaptic potential stimulated 
by neuropeptides generates enough depolarization, to 
remove Mg2 + from the NMDA receptor ion channel, 
that the NMDA receptor is activated and Ca2+ ions 
enter the cell. It is proposed that the changes in 
intracellular Ca2+ and second messengers they affect 
which lead to persistent changes in the excitability of 
the dorsal horn cells. Dubner (1991) expands on this 
theory, suggesting that the neuropeptide-induced facili-
tation of activity at NMDA receptor sites results in 
excessive depolarization and EAA excitotoxicity lead-
ing to cell dysfunction and possibly a loss of normal 
inhibitory mechanisms. The effect of these changes 
include an expansion of dorsal horn receptive fields 
and hyperexcitability which, if allowed to persist, would 
presumably produce prolonged changes in excitability 
that could be maintained without further noxious pe-
ripheral input. 
The most comprehensive model of how noxious 
input can produce prolonged changes in spinal cord 
dorsal horn function has been proposed by Wilcox 
(1991). According to this model, activity in small-diam-
eter primary afferents produces a release of EAAs 
(such as glutamate) and neuropeptides (such as SP) 
into spinal cord dorsal horn. Glutamate produces a fast 
excitatory synaptic potential by acting at the AMP A 
receptor, and a long synaptic potential by acting at the 
NMDA receptor after activity at the AMP A site has 
helped to remove the voltage-gated block of the NMDA 
receptor by Mg2+ ions. While the AMPA effect would 
be brief, lasting only milliseconds to seconds, NMDA 
receptor activation would lead to persistent effects 
such as wind-up, lasting up to tens of seconds. Because 
of its high affinity for its receptor and its slow inactiva-
tion by enzymes, it is proposed that dissociation of SP 
from its receptors would take from several seconds up 
to minutes. In addition to producing a slow depolariza-
tion, SP may either stimulate glutamate release, or 
enhance activation of the NMDA receptor by relieving 
the Mg2+ dependent block. Activation of the SP recep-
tor would also stimulate PLC activity, resulting in the 
production of IP3 and DAG, second messengers which 
would produce intracellular changes lasting many min-
utes to hours. From our own studies (Coderre 1992; 
Coderre and Melzack 1992a) described earlier, we 
would argue that nociception is also influenced by the 
stimulation of PLC activity by glutamate and aspartate 
acting at metabotropic EAA receptor sites. 
According to Wilcox (1991), the noxious stimulus-in-
duced release of excitatory neurotransmitters could 
also produce long-term changes (hours to days) in 
cellular processes by stimulating the induction of early 
immediate genes such as c%~~s and c-jun. We would 
expand on this model by arguing that the induction of 
early immediate genes is triggered by a chain of events 
(see Fig. 1) involving both the influx of Ca2+ through 
NMDA receptor-operated Ca2+ channels, and the ac-
tivation of PLC by both glutamate or aspartate acting 
at metabotropic EAA receptors and SP acting at NK-l 
receptors. The activation of PLC would catalyze the 
hydrolysis of phosphatidylinositol 4,5-bisphosphate 
(PIP2 ) producing IP3 and DAG. DAG would stimulate 
the translocation of PKC, which is activated during 
high rates of Ca2 + influx through NMDA ion channels. 
The activated PKC would have two potential effects: 
first, the phosphorylation of substrate proteins, result-
ing in changes in membrane excitability; and second, 
the production of new gene products, such as Fos and 
Jun. 
An important new development is the demonstra-
tion by Chen and Huang (1992) that PKC produces an 
enhancement of Ca2 + currents at NMDA receptor 
channels. Thus, PKC activation, initiated by glutamate-
or aspartate-induced PLC activity and Ca2 + influx 
through NMDA channels, leads to further influx of 
Ca2+ through NMDA channels, creating a positive 
feedback loop for glutamate and aspartate neurotrans-
mission. Furthermore, the induction of c%~~s is trig-
gered by DAG or activators of PKC, and is dependent 
on Ca2 + influx. As discussed above, it is expected that 
one consequence of c%~~s induction is the transcrip-
tional control encoding the preprodynorphin gene, 
leading to the increased synthesis of dynorphin pep-
tide. Dubner and Ruda (1992) suggest that c-fos-in-
duced increases in dynorphin gene expression and 
dynorphin peptide levels lead to enhanced excitability 
and the development of expanded receptive fields. 
According to their model, dynorphin produces excita-
tory effects on spinal projection neurons, but this exci-
tatory effect is controlled, in part, by negative feedback 
on dynorphin-containing neurons by small inhibitory 
local circuit neurons. They propose that excessive de-
polarization may lead to a pathological state by pro-
moting excitotoxicity and neuronal dysfunction, such as 
the release from inhibition of dynorphin-containing 
neurons following the destruction of the small local 
circuit neurons. It is possible that dynorphin may con-
tribute to spinal hyperexcitability and excitotoxicity by 
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Fig. 1. Schematic diagram indicating a possible mechanism by which 
noxious stimulation or injury leads to central sensitization of spinal 
cord dorsal horn neurons. High levels of afferent input cause the 
release of aspartate. glutamate and substance P (SP) within the 
dorsal horn. Repetitive fast-transmitter activity of aspartate and 
glutamate at AMPA/kainate receptors produces a membrane depo-
larization which would counter a voltage-dependent blockade of the 
NMDA receptor by Mg2+. Activation of neurokinin-! (NK-l) recep-
tors by SP produces a slow, prolonged depolarization and enhances 
influx of extracellular Ca2 + through voltage-gated Ca2 + channels. A 
further action of aspartate and glutamate at NMDA and 
metabotropic receptors, respectively, would produce an influx of 
Ca2+ (through NMDA receptor-operated Ca2+ channels), and the 
activation of phospholipase C (PLC). PLC catalyzes the hydrolysis of 
phosphatidylinositol 4,5-bisphosphate (PIP2) producing ionositol 
trisphosphate (IP3) and diacyclglycerol (DAG), both of which act as 
intracellular second messengers. The production of IP3 causes the 
release of Ca2 + from intracellular stores within the -endoplasmic 
reticulum (ER). The increases in intracellular Ca2+ produced by the 
influx of ea2 + through voltage-gated channels, NMDA receptor-op-
erated channels, and by the release of CaZ+ from internal stores, 
results in increased expression of proto-oncogenes such as c-Ios and 
c-jun. The production of DAG stimulates the translocation and 
activation of protein kinase C (PKC), which is activated during high 
rates of Ca2 + influx. The activated PKC induces sustained alter-
ations in the cellular membrane affecting membrane permeability for 
prolonged periods. In particular, PKC produces an enhancement of 
ionic current at the NMDA receptor, allowing for additional extra-
cellular Ca2+ to enter the cell. PKC also interacts with ea2+ to 
stimulate further increases in the expression of the proto-oncogenes 
c-Ios and c-jun. The protein products of these proto-oncogenes 
participate in the regulation of mRNA encoding dynorphin and 
en kephalin peptides in spinal cord, and can influence long-term 
changes in cellular function. 
producing a specific postsynaptic facilitation of NMDA 
receptor activity. Support for this mechanism comes 
from recent studies of Skilling et aI. (1992b) which 
demonstrated that dynorphin augments nociceptive be-
haviors induced by intrathecal administration of 
NMDA, and Bakshi et al. (1992) who found that 
NMDA antagonists block the motor deficits and neu-
rotoxic histological changes induced by high dose 
dynorphin A. 
Implications for treatment of acute and chronic pain 
Recent advances in our understanding of the mech-
anisms that underlie pathological pain have important 
implications for the treatment of both acute and chronic 
pain. Since it has been established that intense noxious 
stimulation produces a sensitization of CNS neurons, it 
is possible to direct treatments not only at the site of 
peripheral tissue damage, but also at the site of central 
changes. Furthermore, it may be possible in some 
instances to prevent the development of central changes 
which contribute to pathological pain states. The fact 
that amputees are more likely to develop phantom 
limb pain if there is pain in the limb prior to amputa-
tion (Melzack 1971; Katz and Melzack 1990), combined 
with the finding that the incidence of phantom limb 
pain is reduced if patients are rendered pain-free by 
epidural blockade with bupivacaine and morphine prior 
to amputation (Bach et al. 1988), suggests that the 
development of neuropathic pain can be prevented by 
reducing the potential for central sensitization at the 
time of amputation. The evidence that postoperative 
pain is also reduced by premedication with regional 
and/or spinal anesthestic blocks and/or opiates (Mc-
Quay et al. 1988; Tverskoy et al. 1990; Katz et al. 1992) 
suggests that acute postoperative pain can also benefit 
from the blocking of the afferent barrage arriving within 
the CNS, and the central sensitization it may induce. 
Whether chronic postoperative problems such as 
painful scars, post-thoracotomy chest-wall pain, and 
phantom limb and stump pain can be reduced by 
blocking nociceptive inputs during surgery remains to 
be determined. Furthermore, additional research is 
required to determine whether multiple-treatment ap-
proaches (involving local and epidural anesthesia, as 
well as pretreatment with opiates and anti-inflamma-
tory drugs) which produce an effective blockade of 
afferent input (Dahl et al. 1990), may also prevent or 
relieve other forms of severe chronic pain such as 
post-herpetic neuralgia and reflex sympathetic dystro-
phy. 
Evidence indicating that neuropeptides and EAAs 
contribute to the development of noxious stimulus-in-
duced central neuroplasticity outlines the potential for 
the use of selective receptor antagonists in pain treat-
ment. The recent development of non-peptide neu-
rokinin receptor antagonists (Snider et al. 1991), and of 
new agents that act at various sites within the NMDA 
receptor complex (see Lodge and Johnson 1991), may 
provide fruitful new tools for the treatment and pre-
vention of pathological pain. Particularly exciting is the 
development of a new class of agents which block the 
binding of glycine to the NMDA receptor complex and 
prevent the allosteric potentiation by glycine of activity 
at the NMDA receptor binding site (Birch et al. 1988; 
Kemp ct at. \988). These agents cross the blood-brain 
barrier more easily than antagonists which act competi-
tively at the NMDA receptor, and may not produce the 
psychomimetic side effects produced by dissociative 
anesthetics (such as ketamine). Also, since neuropep-
tide and EAA activity results in Ca2 + influx (Mac-
Dermott et at. 1986) and the activation of PLC-related 
second messenger systems (Sugiyama et al. 1987), it is 
possible that agents which inhibit second messenger 
cascades may be useful for the treatment of pathologi-
cal pain. An intriguing possibility is the use of ganglia-
sides, which block glutamate-stimulated translocation 
of PKC (Vaccarino et al. 1987), and have recently been 
found to reduce hyperalgesia in a rat model of periph-
eral neuropathy (Hayes et al. 1992). It is hoped that a 
combination of new pharmaceutic developments, care-
ful clinical trials, and an increased understanding of 
the contribution and mechanisms of noxious stimulus-
induced neuroplasticity, will lead to improved clinical 
treatment and prevention of pathological pain. 
Conclusions 
Clinical and experimental evidence suggests that 
noxious stimuli may sensitize central neural structures 
involved in pain perception. Salient clinical examples 
of these effects include amputees with pains in a phan-
tom limb that are similar or identical to those felt in 
the limb before it was amputated, and patients after 
surgery who have benefited from pre-emptive analgesia 
which . blocks the surgery-induced· afferent barrage 
and/or its central consequences. Experimental evi-
dence of these changes is illustrated by the develop-
ment of sensitization, wind-up or expansion of recep-
tive fields of CNS neurons, as well as by the enhance-
ment of flexion reflexes and the persistence of pain or 
hyperalgesia after inputs from injured tissues are 
blocked. It is clear from the material presented that 
the perception of pain does not simply involve a mo-
ment-to-moment analysis of afferent noxious input, but 
rather, involves a dynamic process which is influenced 
by the effects of past experiences. Sensory stimuli act 
on neural systems which have been modified by past 
inputs, and the behavioral output is significantly influ-
enced by the 'memory' of these prior ·events. Unlike 
previous theories of central sensitization, recent theo-
ries propose that in addition to a contribution of neu-
ronal hyperactivity to pathological pain, there are spe-
cific cellular and molecular changes that affect mem-
brane excitability and induce new gene expression. 
thereby allowing for enhanced responses to future 
stimulation. An increased understanding of the central 
changes induced by peripheral injury or noxious stimu-
lation should lead to new and improved clinical treat-
ment for the relief and prevention of pathological pain. 
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